Publications by authors named "N A Poulsen"

Introduction/aims: Primary hypokalemic periodic paralysis (HypoPP) can present with periodic paralysis and/or permanent muscle weakness. Permanent weakness is accompanied by fat replacement of the muscle. It is unknown whether the permanent muscle weakness is solely due to fat replacement or if other factors affect the ability of the remaining muscle fibers to contract.

View Article and Find Full Text PDF

This study explores the feasibility of utilizing in vitro cultivated milk-derived bovine mammary epithelial cells (bMECs) for the production of milk constituents. BMECs were isolated from milk and treated with various lactogenic agents in 3D transwell systems. By proteomics, >900 proteins were identified and quantified in the secretomes, including >100 milk-related proteins such as caseins and enzymes.

View Article and Find Full Text PDF

Background/objectives: Type 2 diabetes (T2D) is one of the most common global diseases, with an ever-growing need for prevention and treatment solutions. Kale ( L. var.

View Article and Find Full Text PDF

Context And Objectives: The human calcium-sensing receptor (CaSR) plays a key role in calcium homeostasis, and most identified CASR variants are associated with hypercalcemic and hypocalcemic disorders. Here we characterized the pharmacological implications of five heterozygous CASR variants from individuals with familial hypocalciuric hypercalcemia 1 [FHH1: Y63C, I81T, Q459R, W818stop] or autosomal dominant hypocalcemia 1 [ADH1: R955stop].

Methods: Total and cell surface expression levels of wild-type (WT) and variant CaSRs expressed in human embryonic kidney 293T (HEK293T) cells were determined using ELISA, and the pharmacological properties of the receptors were delineated in two functional assays.

View Article and Find Full Text PDF
Article Synopsis
  • Sperm production requires effective communication between Sertoli cells and germ cells, and researchers studied how RANKL activity in Sertoli cells affects this process.
  • They found that using the RANKL inhibitor denosumab led to increased testicular weight and germ cell growth in testis cultures and a specific mouse model.
  • In a clinical trial, while denosumab didn't improve overall semen quality, it did increase sperm concentration in infertile men with higher levels of anti-müllerian hormone (AMH), indicating a potential targeted treatment approach for male infertility based on AMH levels.
View Article and Find Full Text PDF